Smarter in Minutes #4: Remdesivir
Pre-Assessment

Before you view the activity, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit.

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit. There is no fee to participate in this activity.

Question Title

* 1. HCPs: What are your credentials?

ID MD/DO

PCP, FM, GP MD/DO

IM MD/DO

Geriatrician MD/DO

APP (NP or PA)

PharmD

Other (please specify)

Question Title

* 2. In the outpatient adult setting, RDV should be administered:

Within 5 days of symptom onset for 5 days

Within 5 days of symptom onset for 10 days

Within 7 days of symptom onset for 3 days

Within 7 days of symptom onset for 5 days

Question Title

* 3. RDV in the outpatient setting requires:

Five continuous day administration with a nasogastric or orogastric tube

Three continuous days of IV dosing (day 1, loading dose; day 2,3, maintenance dose)

Dosage adjustments for patients with renal impairment (eGFR<60 mL/min)

Dose adjustments for concomitant CYP3A4 substrate medications

Question Title

* 4. High risk outpatients with symptom onset < 7 days and at least one pre-existing risk factor for progression to severe COVD (eg, ≥60 years of age, hypertension, obesity, chronic mild/moderate kidney disease, etc) benefitted from how many days of IV remdesivir therapy in the pivotal PINETREE outpatient trial?

1 day

3 days

5 days

7 days

Question Title

* 5. The daughter of a 73-year-old male smoker with a medical history of dysphagia, pulmonary hypertension, and peripheral arterial disease reports her father has tested positive by PCR for COVID-19. As his full-time caretaker, she would prefer to avoid any treatment requiring a hospital admission. Of the following options, what is his best treatment option?

O2 via HFNC

Molnupiravir

Paxlovid

Remdesivir (since the dysphasia would make it difficult for him to swallow oral medication)

Question Title

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).

First Name

Last Name

Degree/Credentials

State/Province

ZIP/Postal Code

Country

Email Address (required to receive credit)

Smarter in Minutes #4: Remdesivir ***Pre-Assessment***

Question Title

* 1. HCPs: What are your credentials?

Question Title

* 2. In the outpatient adult setting, RDV should be administered:

Question Title

* 3. RDV in the outpatient setting requires:

Question Title

Question Title

Question Title

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).

Smarter in Minutes #4: Remdesivir
Pre-Assessment